Beam Therapeutics Inc. (NASDAQ:BEAM)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $156.0M
- Net income
- -$85.4M
- Net margin
- -54.7%
Little or no net debt.
- Total debt
- $247.4M
- Cash
- $219.8M
- Debt / equity
- 0.23
Comfortably covers what is due within a year.
- Current assets
- $1.18B
- Current liabilities
- $80.9M
- Current ratio
- 14.57
Consumes cash and must keep raising it.
- Operating cash flow
- -$359.4M
- Free cash flow
- -$372.8M
- FCF margin
- -238.9%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 104.3M
- Share growth (1y)
- 2.3%
- Cash runway
- 7 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BEAM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 490.00 K | 31.74 M | 114.11 M | 9.70 M | 8.47 M | 7.47 M |
| Revenue Growth (YoY) | -94.21 % | 324.87 % | 279.52 % | -32.03 % | -28.08 % | 0.81 % |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 490.00 K | 31.74 M | 114.11 M | 9.70 M | 8.47 M | 7.47 M |
| SG&A Expense | 31.95 M | 34.43 M | 32.28 M | 26.74 M | 26.86 M | 27.94 M |
| R&D Expense | 95.10 M | 104.52 M | 99.28 M | 109.77 M | 101.76 M | 98.82 M |
| Operating Expenses | 127.04 M | 138.95 M | 131.55 M | 136.51 M | 128.62 M | 126.76 M |
| Operating Income | -126.55 M | -107.22 M | -17.45 M | -126.81 M | -120.15 M | -119.29 M |
| Pretax Income | -122.68 M | -94.32 M | 244.30 M | -112.73 M | -102.29 M | -109.27 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -122.68 M | -94.32 M | 244.30 M | -112.73 M | -102.29 M | -109.27 M |
| EPS (Basic) | -1.18 | -0.91 | 2.37 | -1.10 | -1.00 | -1.24 |
| EPS (Diluted) | -1.18 | -0.91 | 2.33 | -1.10 | -1.00 | -1.24 |
| Shares Outstanding | 104.33 M | 103.26 M | 102.88 M | 102.57 M | 102.00 M | 87.98 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.